Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xingfei Pan has a total of 115 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Huang

    Department of Infectious Diseases, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, China

    13 shared publications
  • Hongyan Xie

    Laboratory of Immunology, School of Basic Medicine Guangzhou Medical University Guangzhou China

    10 shared publications
  • Liyang Zhou

    Department of Infectious Diseases, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University

    9 shared publications
  • Xueting Ou

    Department of Infectious Diseases, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University

    8 shared publications
  • Dianhui Chen

    Department of Infectious Diseases, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    7 shared publications
  • Feng Mo

    Department of Infectious Diseases, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China

    7 shared publications

Latest Publications

  • Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection

    by Andrew J. Park, Bai L. Pan, Xingfei Pan, James Park, Jiahong Dong, Calvin Q. Pan

    Background and Aims: Chronic hepatitis B virus (HBV) infection remains a major cause of hepatocellular carcinoma (HCC). Although antiviral therapy reduces cirrhosis and liver failure, HCC may still develop in patients with HBV, including in non‐cirrhotic livers. This review aimed to evaluate current HCC surveillance strategies in HBV infection, focusing on risk stratification and advances in early detection. Methods: English‐language literature published in PubMed and the Cochrane Database was comprehensively reviewed. This narrative review assessed the effectiveness of HCC surveillance strategies in HBV‐infected patients, with emphasis on recent advances in early‐stage HCC detection. Results: This review summarizes viral, host and environmental factors associated with HCC susceptibility and evaluates current surveillance using ultrasound with or without alpha‐fetoprotein (AFP). Surveillance eligibility should follow guideline‐defined risk criteria: patients with an estimated annual HCC risk below 0.2% generally do not require routine surveillance and should undergo periodic risk reassessment, whereas patients meeting surveillance criteria should undergo ultrasound with or without AFP every 6 months. Risk‐prediction scores can refine assessment but should be distinguished from early‐detection tests. GALAD, HES 2.0, multi‐target blood tests, and abbreviated magnetic resonance imaging are promising early‐detection approaches, but much of the supporting evidence derives from mixed‐aetiology or non‐HBV cohorts and prospective HBV‐specific validation remains limited. Conclusion: A risk‐adapted approach should separate estimation of future HCC risk from surveillance and early‐detection testing. Guideline‐eligible patients should undergo surveillance every 6 months, while emerging biomarker, imaging and artificial‐intelligence approaches remain adjunctive or investigational pending further HBV‐specific validation.

  • Open Access

    Multi-platform evidence of GSDMD-dependent pyroptosis in malaria with a potential role for TLR7

    by Yumei Gong, Yiwei Liu, Longkun Li, Jialin Geng, Ying Huang, Lixin Luo, Xinyue Wang, Long Xu, Yongtao Zhang, Xingfei Pan, et al.

    Background: Macrophage-mediated inflammation critically determines malaria pathology. Although pyroptosis contributes to host defense, excessive activation induces severe immunopathology. The precise pyroptotic pathways in splenic macrophages during Plasmodium infection, and the upstream regulatory mechanisms that govern them, remain unclear. Methods: We integrated clinical transcriptomic analysis (GSE132050), Plasmodium yoelii infected mouse models, and in vitro macrophage assays to systematically investigate pyroptosis mechanisms and to evaluate the regulatory role of the Toll-like receptor 7 (TLR7) agonist R848. Results: Clinical data revealed significant up-regulation of core pyroptosis genes (GSDMD, CASP1/4/5) in malaria patients, correlated with myeloid expansion. In vivo , P. Yoelii infection was associated with activation of both canonical and non-canonical gasdermin D (GSDMD) related pyroptotic signaling in CD11b + F4/80 + splenic macrophages. In vitro , infected red blood cell (iRBC) lysates directly triggered post-translational cleavage of Caspase-1/11 and GSDMD, causing rapid membrane perforation and inflammatory efflux. Notably, in vivo administration of R848 significantly suppressed this pyroptotic activation, exerting a particularly strong inhibitory effect on the Caspase-11/GSDMD non-canonical pathway. Conclusions: Plasmodium infection is associated with canonical and non-canonical pyroptosis in splenic macrophages. R848 treatment was associated with reduced pyroptotic signaling in splenic macrophages, suggesting a regulatory role for TLR7.

  • Characteristics of Splenic CD8αβ + γδT Cells in Plasmodium yoelii Infection

    by Xingfei Pan, Li Pan, Xingyue Wang, Meiling Liu, Haiwen Yuan, Mingjie Chen, Xiongyu Xie, Qi Ye, Lixin Luo, Guikuan Liang, et al.

    γδT cells are a subset of innate lymphocytes that play an essential role in anti‐infection immunity. However, the functional role of CD8αβ + γδT cells, a distinct subset of γδT cells, remains poorly characterized during malaria infection. Female C57BL/6 mice were intraperitoneally injected with 1 × 10 6 Plasmodium yoelii ‐infected red blood cells (iRBCs). At 12 days post‐infection (12 dpi, the peak of parasitemia), spleens were harvested and lymphocytes were isolated. Fluorescence‐activated cell sorting (FACS) was performed to determine the frequency, phenotypic features and functional properties of CD8αβ + γδT cells. Meanwhile, CD45 + lymphocytes were sorted for single‐cell RNA sequencing (scRNA‐seq) to compare differentially expressed genes between CD8αβ + γδT and CD8αα + γδT cell subsets. FACS analysis revealed a significant increase in CD8αβ + γδT cells following P. yoelii infection. These cells exhibited elevated expression of activation‐related molecules, enhanced effector functions, preferential polarization towards an IFN‐γ‐producing (γδT1) phenotype, and reduced expression of exhaustion markers. scRNA‐seq further demonstrated that CD8αβ + γδT cells upregulated genes involved in DNA replication and repair. Our findings indicate that CD8αβ + γδT cells upregulate molecules associated with activation and function during P. yoelii infection, suggesting that they may play a more prominent role in host defence against malaria.

  • Open Access

    A retrospective analysis of coagulation function indicators in acute fatty liver of pregnancy

    by Panpan Zhai, Jing Hu, Xueting Ou, Liyang Zhou, Xingfei Pan

    Background: Acute Fatty Liver of Pregnancy (AFLP) is a rare but life-threatening obstetric emergency. Coagulation dysfunction is a core pathophysiological feature and a key risk factor for adverse events. This study retrospectively analyzed 92 AFLP patients to evaluate the association between coagulation indicators and multiple adverse outcomes, and obtain primary indicator that can predict the severity of disease. Methods: This retrospective cohort study included 92 AFLP patients treated at our hospital from 2017 to 2023. We collected clinical manifestations, laboratory data, and composite adverse outcomes including ICU admission, maternal complications. Logistic regression with variance inflation factor (VIF) diagnostics was used to analyze independent correlates of adverse outcomes. Receiver operating characteristic (ROC) analysis was performed for single indicators. Results: INR (AUC 0.837) and PT (AUC 0.837) showed the strongest individual predictive performance for composite adverse outcomes, these two indicators are the mostsensitive in predicting severity of AFLP. The VIF value of PT is greater than 10, indicating severe multicollinearity. The VIF value of INR was less than 5, and was independently associated with higher rates of MODS, DIC, postpartum hemorrhage. Conclusion: Coagulation function indicators are strongly associated with adverse clinical events in AFLP. INR provides improved risk stratification performance over other markers and may support clinical decision-making. This preliminary indicator requires external validation before routine clinical use.


  • Open Access

    The LEF1–LAG3 axis regulates CD4+ T cell function during Plasmodium yoelii NSM infection

    by Wenbo Peng, Guikuan Liang, Keyu Lu, Feng Mo, Xiongyu Xie, Mingjie Chen, Haiwen Yuan, Lixin Luo, Xingyue Wang, Long Xu, et al.

    Background: CD4⁺ T cells are pivotal in coordinating anti-malarial immunity, while co-inhibitory receptors such as LAG3 critically regulate their function. However, the phenotype of LAG3⁺CD4⁺ T cells during Plasmodium infection and the upstream molecular mechanisms regulating LAG3 expression remain incompletely elucidated. Methods: We established a murine model using Plasmodium yoelii NSM ( P. yoelii NSM). A multifaceted approach, incorporating single-cell RNA sequencing (scRNA-seq), flow cytometry, magnetic bead-based cell sorting, real-time quantitative polymerase chain reaction (RT–qPCR), dual-luciferase reporter assays, and in vitro cultures with the Wnt agonist CHIR99021, was employed. We characterized splenic CD4⁺ T cell dynamics, the phenotypic and functional profiles of LAG3⁺CD4⁺ T cells, and the transcriptional regulatory relationship between lymphoid enhancer-binding factor 1 (LEF1) and Lag3 . Results: Plasmodium yoelii NSM infection induced significant splenomegaly and remodeling of the splenic CD4⁺ T cell compartment, with increased absolute numbers of CD4⁺ T cells, upregulated activation markers (ICOS, CD69), downregulated naïve marker CD62L, and enhanced secretion of IL-10 and IFN-γ. Both scRNA-seq and flow cytometry confirmed that infection markedly upregulated LAG3 on CD4⁺ T cells. These LAG3⁺CD4⁺ T cells exhibited an activated phenotype, characterized by increased proliferative capacity (Ki67⁺), an increased proportion of the effector phenotype (CD44ʰⁱCD62Lˡᵒ), and concurrent upregulation of multiple co-inhibitory receptors (PD-1, TIM-3, TIGIT). Mechanistically, LEF1 expression was significantly downregulated in CD4⁺ T cells post infection. Dual-luciferase reporter assay demonstrated that LEF1 directly binds to the Lag3 promoter, acting as a transcriptional repressor. Furthermore, treatment with the Wnt agonist CHIR99021, which stabilizes the upstream signaling of LEF1, dose-dependently reduced the frequency of LAG3⁺CD4⁺ T cells. Conclusions: This study suggests that the LEF1–LAG3 axis is involved in modulating CD4⁺ T cells during P. yoelii NSM infection. LAG3⁺CD4⁺ T cells exhibit an activated phenotype with regulatory potential, which may contribute to balancing anti-parasitic immunity and immunopathology. These findings suggest that modulating LEF1-mediated transcriptional repression of Lag3 offers a promising avenue for fine-tuning anti-malarial immune responses.

  • Open Access

    TGF-β regulated Tim-3 sustains macrophage phagocytic function and confers protection in Plasmodium yoelii NSM-infected mice

    by Xiongyu Xie, Guikuan Liang, Mingjie Chen, Lixin Luo, Haiwen Yuan, Shenao Chen, Keyu Lu, Wenbo Peng, Long Xu, Hongyan Xie, et al.

    Background: T-cell immunoglobulin and mucin domain 3 (Tim-3) is a critical immune checkpoint, yet its role in regulating macrophage function during malaria infection remains poorly understood. Methods: We established a Plasmodium yoelii NSM murine model, in vitro co-culture systems, and comprehensive techniques including scRNA-seq, flow cytometry, and functional assays to investigate Tim-3 expression on splenic macrophages and its immunoregulatory impact. Results: We observed a significant infection-induced downregulation of Tim-3 on splenic macrophages. Transcriptomic profiling revealed that Tim-3 + macrophages exhibited enhanced antigen presentation and a proinflammatory phenotype characterized by elevated reactive oxygen species (ROS) and proinflammatory cytokine production. Blockade of Tim-3 in vivo exacerbated disease severity, increased parasitemia, and impaired macrophage phagocytic capacity, without directly affecting T-cell responses. Mechanistically, we identified transforming growth factor-beta (TGF-β) as a key upstream regulator of Tim-3 expression, as TGF-β signaling was suppressed during infection, and its stimulation or inhibition correspondingly upregulated or downregulated Tim-3. Furthermore, TGF-β-induced Tim-3 upregulation potentiated macrophage phagocytosis of infected red blood cells (iRBCs) and conferred protection against iRBC-induced cell death. Conclusions: Our results reveal a novel protective TGF-β–Tim-3 axis that maintains the phagocytic function of macrophages and immune homeostasis in Plasmodium yoelii NSM infection. These findings highlight Tim-3 on macrophages as a potential therapeutic target for modulating host defense against malaria infection. Graphical

  • Open Access

    Characteristics of CD103+CD8+ T cells in the spleen of Plasmodium yoelii NSM-infected mice

    by Xingfei Pan, Feihu Shi, Shanni Tang, Meilin Liu, Li Pan, Guikuan Liang, Lu Li, Hongyan Xie, Shan Zhao, Jun Huang

    Background: CD8 + T cells play a critical role in controlling Plasmodium infection. CD103, an integrin composed of αE and β7 subunits, is widely recognized as a cell surface marker for tissue-resident memory T (TRM) cells and tumor-infiltrating lymphocytes (TILs). Methods: In this study, a Plasmodium infection model was constructed by intraperitoneally injecting 10 6 infected red blood cells (iRBCs) into C57BL/6 mice. CD45 + cells in the spleen of naïve and infected mice were sorted and subjected to single-cell RNA sequencing (scRNA-seq). The content, activation, and function of CD103 + CD8 + T cells were detected using flow cytometry. qPCR and dual-luciferase reporter assays were performed to find the key transcription factor. Results: Here, we identified a substantial subset of CD103 + CD8 + T cells in the spleen of naïve mice, whose proportion and count declined rapidly following Plasmodium yoelii NSM infection. Compared to CD103 − CD8 + T cells, in both naïve and infected mice, CD103 + CD8 + T cells exhibited higher CD62L expression and lower levels of CD44, CD69, and TIGIT, and they rarely secreted IFN-γ or granzyme B upon PMA plus Ionomycin (PI) stimulation. Single-cell RNA sequencing revealed that differentially expressed genes (DEGs) were enriched in pathways related to “cytoplasmic translation” and “ribosome biosynthesis”, suggesting that these cells are in a pre-activation preparatory state. Bioinformatics predictions and dual-luciferase reporter assays indicated that the transcription factor LEF1 may regulate Itgae transcription by binding to its promoter sequence. Conclusions: Collectively, our findings demonstrate that splenic CD103 + CD8 + T cells express fewer activation and function-associated molecules, which may contribute to their limited role in the course of P. yoelii NSM infection in C57BL/6 mice, and implicates LEF1 in the regulation of CD103 expression.


  • Open Access

    Global burden of hepatitis C virus infection related to high body mass index and future forecast: an analysis based on the global burden of disease study 2021

    by Jiayi Chen, Shiyun Wu, Panpan Zhai, Xueting Ou, Liyang Zhou, Xingfei Pan

    Objective: The global prevalence of obesity is rising, and prior research has established a strong link between obesity and hepatitis C prognosis. However, the impact of high body mass index (HBMI) on the HCV burden remains uncertain. This study sought to clarify the overall HCV burden related to HBMI and examine temporal trends. Methods: Public data from the Global Burden of Disease (GBD) database (1990–2021) were utilized to analyze the global and different Socio-demographic index (SDI) regional burden of HCV associated with obesity, focusing on Deaths, Disability-Adjusted Life Years (DALYs), Years Lived with Disability (YLDs), and Years of Life Lost (YLLs). Trends in the HCV burden were assessed using Estimated Annual Percentage Changes (EAPCs) and Average Annual Percentage Changes (AAPCs) via Joinpoint regression. The age-period-cohort (APC) model was used to examine the effects of age, period, and cohort on disease burden, respectively. The Das Gupta decomposition analysis method was applied to evaluate the contributions of population growth, population aging, and epidemiological changes to the burden. Frontier analysis was conducted to explore the relationship between the HCV burden linked to HBMI and Socio-demographic development. An ARIMA model was then developed to forecast the Age-standardized Mortality Rate (ASMR) and Age-standardized DALYs Rate (ASDR) of HBMI-associated hepatitis C over the next 15 years. Results: From 1990 to 2021, global HCV deaths related to obesity rose from 3,835 to 17,090, with DALYs increasing from 94,503 to 389,263. The EAPCs for ASMR and ASDR were 2.20 and 2.10, respectively. Obesity posed a greater burden on female patients infected with HCV virus compared to males. In terms of age, the effect of HBMI on HCV patients increased with age. Over the past 30 years, ASMR and ASDR have consistently risen across all SDI regions (All regions: EAPCs > 0, 95% CIs > 0). The High SDI region reported the highest deaths, DALYs, ASMR, and ASDR annually, indicating the greatest obesity impact on HCV burden of this area. However, obesity also had an increasingly large impact on the HCV disease burden in the Middle SDI and Low-middle SDI regions. Regionally, Africa, the Middle East, and Central Asia bear a relatively heavy burden of HCV associated with HBMI, and the burden in North America and Oceania cannot be ignored. At the national level, Mongolia and Egypt have the heaviest burden. The results of decomposition analysis show that epidemiological changes are the main cause of the increased burden. Projections suggest a continued increase in the obesity-related HCV burden globally and across different SDI regions over the next 15 years. Conclusion: Obesity poses an increasing disease burden for people infected with hepatitis C virus. Targeted public health interventions are urgently needed to alleviate this burden.


  • Chronic Hepatitis B in Women of Childbearing Age and Pregnant Women in China: A Cross-Sectional Study

    by Liyang Zhou, Xitao Liu, Xueting Ou, Qiongyu Sheng, Bing Situ, Fang He, Xingfei Pan

    Pregnant women and women of childbearing age were enrolled in our study and their knowledge about the Hepatitis B virus (HBV) and chronic hepatitis B (CHB) was evaluated. A questionnaire was distributed to every woman in the cross-sectional study. The questionnaire was answered by all participants before they received health education and advice about HBV and CHB from the doctors visited. Data collected from all answers were analyzed using the χ2 test and logistic regression models. A total of 206 pregnant women and women of childbearing age with CHB infection were enrolled in the study during their first visit to the Infectious Diseases Clinic of the Third Affiliated Hospital of Guangzhou Medical University. Some women of childbearing age (40.8%) and pregnant women with CHB infection (30.6%) still believed HBV could be transmitted through diet and/or mosquito bites. Some women of childbearing age and pregnant women with CHB infection had limited knowledge of the prevention of HBV transmission (111 of 206, 53.9%). Women with higher levels of education had more knowledge about HBV (senior middle school, P = 0.02; university, P < 0.01). The majority of participants were willing to take antiviral medicine to decrease the mother-to-child transmission (MTCT) rate of HBV. Some women of childbearing age and/or pregnant women with CHB infection have relatively limited knowledge about HBV or CHB. This situation contributes to the timeliness, or lack thereof, of these women with CHB to see a doctor and receive antiviral therapy. As a result, the morbidity and mortality of HBV-related complications could increase along with the rate of MTCT of HBV.